Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify an optimal weight based dose of azathioprine that is
safe and effective in the treatment of subjects with active Crohn's disease requiring
treatment with corticosteroids, and for maintaining remission in those subjects.